
DataVault AI, Inc. (NASDAQ:DVLT) and Wellgistics Health, Inc. (NASDAQ:WGRX) are collaborating to bring blockchain technology to the U.S. prescription drug market.
Through a non-binding letter of intent, the companies plan to integrate DataVault’s blockchain platform with Wellgistics’ digital and physical infrastructure to streamline drug tracking, improve transparency, and enhance patient safety.